{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:13:32Z","timestamp":1761585212508,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["470455\/2013-6"],"award-info":[{"award-number":["470455\/2013-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.intimp.2017.04.014","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T05:34:48Z","timestamp":1493098488000},"page":"227-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Evaluation of vaccinal effectiveness of preparations containing membrane antigens of Leishmania (L.) amazonensis in experimental cutaneous leishmaniasis model"],"prefix":"10.1016","volume":"47","author":[{"given":"Jo\u00e3o G.","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e1lia S.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon R.A.","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norton R.D.L.P.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayara C.P.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosane N.M.","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neuza B.","family":"de Barros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Nicolete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2007","series-title":"Manual de Vigil\u00e2ndia em Leishmaniose Tegumentar americana","author":"Brasil. Minist\u00e9rio da Sa\u00fade","key":"10.1016\/j.intimp.2017.04.014_bb0005"},{"key":"10.1016\/j.intimp.2017.04.014_bb0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","article-title":"New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment","volume":"63","author":"Mitropoulos","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2017.04.014_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vetpar.2007.03.037","article-title":"Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation","volume":"147","author":"Day","year":"2007","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.intimp.2017.04.014_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/biohorizons\/hzp004","article-title":"Leishmania vaccines: from leishmanization to the era of DNA technology","volume":"2","author":"Dunning","year":"2009","journal-title":"Biosci. Horiz."},{"key":"10.1016\/j.intimp.2017.04.014_bb0025","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.intimp.2011.05.008","article-title":"Vaccine candidates for leishmaniasis: a review","volume":"11","author":"Nagill","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2017.04.014_bb0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/02652048.2014.958203","article-title":"Nanobiotechnologic approach to a promising vaccine prototype for immunisation against leishmaniasis: a fast and effective method to incorporate GPI-anchored proteins of Leishmania amazonensis into liposomes","volume":"32","author":"Colhone","year":"2015","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.intimp.2017.04.014_bb0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0168-3659(93)90097-O","article-title":"Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with d,l-lactide\/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior","volume":"25","author":"Niwa","year":"1993","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2017.04.014_bb0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.prostaglandins.2006.10.007","article-title":"In vitro and in vivo activities of leukotriene B4-loaded biodegradable microspheres","volume":"83","author":"Nicolete","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.intimp.2017.04.014_bb0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.intimp.2016.04.025","article-title":"Liposomes containing an ASP49-phospholipase A2 from Bothrops jararacussu snake venom as experimental therapy against cutaneous leishmaniasis","volume":"36","author":"De Barros","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2017.04.014_bb0050","series-title":"Immunochemistry in Practice","first-page":"241","article-title":"Immunoassays","author":"Thorpe","year":"1987"},{"key":"10.1016\/j.intimp.2017.04.014_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1590\/0074-02760160280","article-title":"Phenotypic diversity and selection maintain Leishmania amazonensis infectivity in BALB\/C mouse model","volume":"112","author":"Espiau","year":"2017","journal-title":"Mem Inst Oswaldo Cruz Rio Janeiro"},{"key":"10.1016\/j.intimp.2017.04.014_bb0060","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.140.4.995","article-title":"Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis","volume":"140","author":"Gordon","year":"1974","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2017.04.014_bb0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0264-410X(02)00435-8","article-title":"Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres","volume":"21","author":"Gutierro","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2017.04.014_bb0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.cr.7290257","article-title":"Activation and signaling of the p38 MAP kinase pathway","volume":"15","author":"ZARUBIN","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2017.04.014_bb0075","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1128\/IAI.71.8.4278-4288.2003","article-title":"Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis","volume":"71","author":"Ji","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2017.04.014_bb0080","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1086\/340820","article-title":"Chemokine induced leishmanicidal activity in murine macrophages via the generation of nitric oxide","volume":"185","author":"Bhattacharyya","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2017.04.014_bb0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3347\/kjp.2006.44.1.43","article-title":"Identification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice","volume":"44","author":"Mohammadi","year":"2006","journal-title":"Korean J. Parasitol."},{"key":"10.1016\/j.intimp.2017.04.014_bb0090","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.144.12.4794","article-title":"Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l-arginine","volume":"144","author":"Liew","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2017.04.014_bb0095","first-page":"2115","article-title":"Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11","volume":"7","author":"Santos","year":"2012","journal-title":"Int. J. Nanomedicine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917301480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917301480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:08:39Z","timestamp":1761584919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576917301480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":19,"alternative-id":["S1567576917301480"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2017.04.014","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of vaccinal effectiveness of preparations containing membrane antigens of Leishmania (L.) amazonensis in experimental cutaneous leishmaniasis model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2017.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}